IRIS
PISCIOTTA, LIVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.998
AS - Asia 1.895
NA - Nord America 992
SA - Sud America 173
AF - Africa 33
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 17.096
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.670
US - Stati Uniti d'America 927
SG - Singapore 754
CN - Cina 518
VN - Vietnam 363
FR - Francia 136
BR - Brasile 110
HK - Hong Kong 81
DE - Germania 44
FI - Finlandia 39
MX - Messico 37
AR - Argentina 33
JP - Giappone 21
IN - India 20
BD - Bangladesh 19
GB - Regno Unito 18
IQ - Iraq 18
CA - Canada 16
ID - Indonesia 16
NL - Olanda 15
RU - Federazione Russa 15
PH - Filippine 11
TH - Thailandia 9
TR - Turchia 9
UA - Ucraina 9
CL - Cile 8
ES - Italia 7
PK - Pakistan 7
VE - Venezuela 7
ZA - Sudafrica 7
CH - Svizzera 6
EG - Egitto 6
SA - Arabia Saudita 6
AT - Austria 5
TW - Taiwan 5
AU - Australia 4
EC - Ecuador 4
ET - Etiopia 4
IE - Irlanda 4
NP - Nepal 4
PS - Palestinian Territory 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
MY - Malesia 3
PE - Perù 3
PL - Polonia 3
PY - Paraguay 3
SE - Svezia 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BH - Bahrain 2
BJ - Benin 2
CO - Colombia 2
CR - Costa Rica 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
LB - Libano 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
QA - Qatar 2
RO - Romania 2
SY - Repubblica araba siriana 2
AL - Albania 1
AO - Angola 1
BE - Belgio 1
BY - Bielorussia 1
CM - Camerun 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
HT - Haiti 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
MG - Madagascar 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
NA - Namibia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
TN - Tunisia 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.096
Salva come PNG Salva come JPEG
Città #
Genova 6.663
Genoa 4.654
Vado Ligure 1.098
Rapallo 1.014
Singapore 350
San Jose 260
Ashburn 210
Lauterbourg 124
Ho Chi Minh City 109
Hanoi 92
Beijing 81
Council Bluffs 79
Hong Kong 75
St Louis 60
New York 54
Bordighera 41
Frankfurt am Main 31
Helsinki 31
Santa Clara 26
Mexico City 23
Tokyo 20
Milan 18
Haiphong 17
Rome 14
Chicago 12
Da Nang 12
Orem 12
São Paulo 12
Tianjin 11
Amsterdam 9
Los Angeles 9
Verona 9
Camaiore 8
Biên Hòa 7
Lappeenranta 7
Salt Lake City 7
Turin 7
Baghdad 6
Florence 6
Nuremberg 6
Zurich 6
Bologna 5
City of London 5
Des Moines 5
Hải Dương 5
Nha Trang 5
Riyadh 5
Toronto 5
Addis Ababa 4
Boardman 4
Can Tho 4
Chennai 4
Dallas 4
Dublin 4
Duque de Caxias 4
Madrid 4
Milwaukee 4
Palermo 4
Quảng Ngãi 4
Rio de Janeiro 4
Salvador 4
Shenzhen 4
Sorocaba 4
Sydney 4
Tampa 4
Ankara 3
Atlanta 3
Bangkok 3
Buenos Aires 3
Buffalo 3
Campinas 3
Denver 3
Dhaka 3
Guangzhou 3
Hangzhou 3
Jakarta 3
Lahore 3
London 3
Montevideo 3
Montreal 3
Mosul 3
New Delhi 3
Padua 3
Pescara 3
Petaling Jaya 3
Phú Thọ 3
Prato 3
Quilmes 3
Stockholm 3
Taipei 3
Thái Nguyên 3
Amman 2
Baku 2
Bari 2
Belo Horizonte 2
Berlin 2
Brasília 2
Bratislava 2
Brooklyn 2
Brugherio 2
Totale 15.489
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 321
Manuale di dietistica e dietetica applicata. Vol. 2 256
Lipoproteins, stroke and statins. 216
A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla) 203
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 194
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 191
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 188
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 184
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients. 183
A silent mutation of Niemann-Pick C1-like 1 and apolipoprotein E4 modulate cholesterol absorption in primary hyperlipidemias. 179
A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment. 179
A “de novo” mutation of the LDL-receptor gene as the cause of familial hypercholesterolemia. 174
Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene. 169
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease 168
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 165
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia 164
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). 164
Genetic polymorphisms affecting the phenotypic expression in familial hypercholesterolemia 163
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 163
An apparent inconsistency in parent to offspring transmission of point mutations of LDLR gene in familial hypercholesterolemia. 162
Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison. 162
Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer 161
Carotid ultrasonography in the assessment of cardiovascular risk 160
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 159
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. 158
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2 +5G>C mutation in ABCA1 gene 157
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia. 156
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia. 156
Timely diagnosis of sitosterolemia by next generation sequencing in two children with severe hypercholesterolemia 154
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders. 153
Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease. 153
Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin. 152
A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene 151
Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy. 151
Long term substrate reduction therapy with ezetimibe alone or associated with statins in three adult patients with lysosomal acid lipase deficiency 149
Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs 148
Heterozygosity for lysosomal acid lipase E8SJM mutation and serum lipid concentrations. 147
Efficacy of Nutraceutical Combination of Monacolin K, Berberine, and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic Patients 146
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 144
Adiponectin/leptin ratio predicts the remission of metabolic syndrome: A pilot study 143
Severe HDL deficiency due to novel defects in the ABCA1 transporter. 143
The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia 143
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e. 142
Quantitative polymerase chain reaction and microchip electrophoresis to detect major rearrangements of the low-density lipoprotein receptor gene causing familial hypercholesterolemia. 142
Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency. 142
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 142
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 141
Serum homocysteine, methylenetetrahydrofolate reductase gene polymorphism and cardiovascular disease in heterozygous familial hypercholesterolemia. 139
Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis 139
Physical activity modulates effects of some genetic polymorphisms affecting cardiovascular risk in men aged over 40 years. 136
Two Italian Kindreds Carrying the Arg136>Ser Mutation of Apo E Gene: Development of Premature and Severe Atherosclerosis in the presence of Epsilon 2 as Second Allele 135
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 135
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 135
Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs) 134
Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia. 133
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency. 131
PCSK9 inhibitors for treating hypercholesterolemia 130
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 129
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders 129
Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis 127
Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis 127
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. 125
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 124
Molecular characterization of two patients with severe LCAT deficiency. 122
Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants 122
Changes in the Expression of the Nuclear Matrix Intermediate Filament Complex Proteins are correlated with the Level of Differentiation in Human Prostate Cancer. 122
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 120
First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias 119
Troponin elevation does not always mean cardiac ischemia. 118
Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity 117
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study 114
Influence of beta(0)-thalassemia on the phenotypic expression of heterozygous familial hypercholesterolemia : a study of patients with familial hypercholesterolemia from Sardinia. 114
Pharmacological treatment of a Sardinian patient affected by autosomal recessive hypercholesterolemia (ARH) 113
Denaturing high-performance liquid chromatography (DHPLC) in the detection of mutations of ABCA1 gene in Familial HDL Deficiency. 112
Beta-sitosterolaemia: a new nonsense mutation in the ABCG5 gene. 112
Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia - Brief Report 112
Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies 111
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 110
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment. 108
Online Questionnaire with Fibromyalgia Patients Shows Negative Correlations between Disease Severity and Adherence to Mediterranean Diet 107
Clinical Expression of Familial Hypercholesterolemia in clusters of mutations of LDL-receptor gene causing receptor-defective or receptor-negative phenotype 106
The study of familial hypercholesterolemia in Italy: A narrative review 106
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. 106
Among biomarkers of neutrophil activity, matrix metalloproteinases 8 independently predicts remission of metabolic syndrome 104
Beta-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia. 103
A successful term pregnancy with severe hypertriglyceridaemia and acute pancreatitis. Clinical management and review of the literature 103
Le ipercolesterolemie familiari: forme dominanti e recessive (FH, FDB, FH3, FH4, ARH, beta-sitosterolemia, Deficit di 7alpha-idrossilasi). 102
Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study 101
Effects of a mediterranean diet, dairy, and meat products on different phenotypes of dyslipidemia: A preliminary retrospective analysis 101
Institution of an interdisciplinary IBD centre is associated with improved healthcare utilisation 100
Author Correction: Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity 100
Evaluation of the efficacy of plant sterols supplement sterolip® ESI in patients with type IIA hypercholesterolemia in relation to Genetic variants modulating intestinal absorption of cholesterol 100
Evaluation of RNA messangers involved in lipid trafficking of human intestinal cells by RT-PCR with competimer technology and microchip electrophoresis. 99
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 99
LIPA gene mutations affect the composition of lipoproteins: Enrichment in ACAT-derived cholesteryl esters 95
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy 94
Characterization of Three Kindred with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 94
Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review 93
The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study 93
Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study 93
Totale 13.894
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.829
article - articoli 55.600
book - libri 481
conference - conferenze 88
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 660
Totale 113.658
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021240 0 0 0 0 0 0 0 0 0 102 79 59
2021/20221.289 39 109 100 131 47 100 87 294 77 96 73 136
2022/20231.229 120 80 15 110 176 226 53 87 181 51 114 16
2023/2024981 37 89 22 103 107 187 60 65 35 57 86 133
2024/20252.885 110 186 125 223 293 280 250 466 134 136 300 382
2025/20265.545 637 234 517 673 762 440 863 308 490 621 0 0
Totale 17.504